Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: foam cells

a rat is standing on top of a plastic container
December 18, 2025 CD as API / CD derivatives / Pharma applications

Selective removal of 7-ketocholesterol by a CD-dimer, a novel atherosclerosis therapeutic candidate

The removal of the toxic oxidized cholesterol, 7-ketocholesterol (7KC), from cells through the administration of therapeutics has the potential to

Continue reading

September 28, 2023 CD as API / Drug delivery / Pharma applications

Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis

A disorder of cholesterol homeostasis is one of the main initiating factors in the progression of atherosclerosis (AS). Metabolism and

Continue reading

October 7, 2022 CD as API / Pharma applications / Supramolecular systems

Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis

A promising therapy for atherosclerosis treatment was designed by targeting LXR receptor (LXR) on atherosclerotic macrophage, where LXR activation could

Continue reading

Recent Posts

  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD
  • 9th China International Biotechnology Conference & Exhibition (BIOTEC-CHINA 2027)

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (355)
  • CD derivatives (430)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (816)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (415)
  • Other industrial use (112)
  • Pharma applications (1,218)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • α-CD as laxative for pets and CD as litter deodorant
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Cyclodextrins in veterinary medicine (Part 1)
  • 12th World Meeting on Pharmaceutics, Biopharmaceutics & Pharmaceutical Technology
  • Effect of cyclodextrins on the pigment production of Pseudomonas aeruginosa
  • Lanosterol eye drops for cataract treatment

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...